Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Pharmaceutical Impurity Testing Service refers to the analytical testing of pharmaceutical compounds to identify and quantify impurities or degradation products that may be present in drug substances or drug products. These impurities can arise from different sources such as drug manufacturing processes, storage conditions, or interactions with other chemical moieties. It is crucial to detect and monitor these impurities to ensure the safety, efficacy, and quality of pharmaceutical products, as some of them can cause adverse effects on human health. The testing process usually involves sophisticated analytical techniques such as chromatography, mass spectrometry, or spectroscopy, and must comply with regulatory requirements set by health authorities such as the FDA or EMA.
Global Pharmaceutical lmpurity Testing Service market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharmaceutical lmpurity Testing Service market research.
Key companies engaged in the Pharmaceutical lmpurity Testing Service industry include Charles River, Intertek, Profacgen, Eurofins Analytical Science Laboratories, Inc. (E-ASL), SGS, Element, Drug Development Solutions Limited, Leeder Analytical and Thermo Fisher Scientific, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Pharmaceutical lmpurity Testing Service were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Pharmaceutical lmpurity Testing Service market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pharmaceutical lmpurity Testing Service market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Segment by Type
Segment by Application
By Region
The Pharmaceutical lmpurity Testing Service report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical lmpurity Testing Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Destructive Testing
1.2.3 Non-destructive Testing
1.3 Market by Application
1.3.1 Global Pharmaceutical lmpurity Testing Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Biopharma
1.3.3 New Drug Research & Development
1.3.4 Gene Therapy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical lmpurity Testing Service Market Perspective (2018-2029)
2.2 Pharmaceutical lmpurity Testing Service Growth Trends by Region
2.2.1 Global Pharmaceutical lmpurity Testing Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pharmaceutical lmpurity Testing Service Historic Market Size by Region (2018-2023)
2.2.3 Pharmaceutical lmpurity Testing Service Forecasted Market Size by Region (2024-2029)
2.3 Pharmaceutical lmpurity Testing Service Market Dynamics
2.3.1 Pharmaceutical lmpurity Testing Service Industry Trends
2.3.2 Pharmaceutical lmpurity Testing Service Market Drivers
2.3.3 Pharmaceutical lmpurity Testing Service Market Challenges
2.3.4 Pharmaceutical lmpurity Testing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical lmpurity Testing Service Players by Revenue
3.1.1 Global Top Pharmaceutical lmpurity Testing Service Players by Revenue (2018-2023)
3.1.2 Global Pharmaceutical lmpurity Testing Service Revenue Market Share by Players (2018-2023)
3.2 Global Pharmaceutical lmpurity Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical lmpurity Testing Service Revenue
3.4 Global Pharmaceutical lmpurity Testing Service Market Concentration Ratio
3.4.1 Global Pharmaceutical lmpurity Testing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical lmpurity Testing Service Revenue in 2022
3.5 Pharmaceutical lmpurity Testing Service Key Players Head office and Area Served
3.6 Key Players Pharmaceutical lmpurity Testing Service Product Solution and Service
3.7 Date of Enter into Pharmaceutical lmpurity Testing Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical lmpurity Testing Service Breakdown Data by Type
4.1 Global Pharmaceutical lmpurity Testing Service Historic Market Size by Type (2018-2023)
4.2 Global Pharmaceutical lmpurity Testing Service Forecasted Market Size by Type (2024-2029)
5 Pharmaceutical lmpurity Testing Service Breakdown Data by Application
5.1 Global Pharmaceutical lmpurity Testing Service Historic Market Size by Application (2018-2023)
5.2 Global Pharmaceutical lmpurity Testing Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Pharmaceutical lmpurity Testing Service Market Size (2018-2029)
6.2 North America Pharmaceutical lmpurity Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pharmaceutical lmpurity Testing Service Market Size by Country (2018-2023)
6.4 North America Pharmaceutical lmpurity Testing Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical lmpurity Testing Service Market Size (2018-2029)
7.2 Europe Pharmaceutical lmpurity Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pharmaceutical lmpurity Testing Service Market Size by Country (2018-2023)
7.4 Europe Pharmaceutical lmpurity Testing Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical lmpurity Testing Service Market Size (2018-2029)
8.2 Asia-Pacific Pharmaceutical lmpurity Testing Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pharmaceutical lmpurity Testing Service Market Size by Region (2018-2023)
8.4 Asia-Pacific Pharmaceutical lmpurity Testing Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical lmpurity Testing Service Market Size (2018-2029)
9.2 Latin America Pharmaceutical lmpurity Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pharmaceutical lmpurity Testing Service Market Size by Country (2018-2023)
9.4 Latin America Pharmaceutical lmpurity Testing Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical lmpurity Testing Service Market Size (2018-2029)
10.2 Middle East & Africa Pharmaceutical lmpurity Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pharmaceutical lmpurity Testing Service Market Size by Country (2018-2023)
10.4 Middle East & Africa Pharmaceutical lmpurity Testing Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Detail
11.1.2 Charles River Business Overview
11.1.3 Charles River Pharmaceutical lmpurity Testing Service Introduction
11.1.4 Charles River Revenue in Pharmaceutical lmpurity Testing Service Business (2018-2023)
11.1.5 Charles River Recent Development
11.2 Intertek
11.2.1 Intertek Company Detail
11.2.2 Intertek Business Overview
11.2.3 Intertek Pharmaceutical lmpurity Testing Service Introduction
11.2.4 Intertek Revenue in Pharmaceutical lmpurity Testing Service Business (2018-2023)
11.2.5 Intertek Recent Development
11.3 Profacgen
11.3.1 Profacgen Company Detail
11.3.2 Profacgen Business Overview
11.3.3 Profacgen Pharmaceutical lmpurity Testing Service Introduction
11.3.4 Profacgen Revenue in Pharmaceutical lmpurity Testing Service Business (2018-2023)
11.3.5 Profacgen Recent Development
11.4 Eurofins Analytical Science Laboratories, Inc. (E-ASL)
11.4.1 Eurofins Analytical Science Laboratories, Inc. (E-ASL) Company Detail
11.4.2 Eurofins Analytical Science Laboratories, Inc. (E-ASL) Business Overview
11.4.3 Eurofins Analytical Science Laboratories, Inc. (E-ASL) Pharmaceutical lmpurity Testing Service Introduction
11.4.4 Eurofins Analytical Science Laboratories, Inc. (E-ASL) Revenue in Pharmaceutical lmpurity Testing Service Business (2018-2023)
11.4.5 Eurofins Analytical Science Laboratories, Inc. (E-ASL) Recent Development
11.5 SGS
11.5.1 SGS Company Detail
11.5.2 SGS Business Overview
11.5.3 SGS Pharmaceutical lmpurity Testing Service Introduction
11.5.4 SGS Revenue in Pharmaceutical lmpurity Testing Service Business (2018-2023)
11.5.5 SGS Recent Development
11.6 Element
11.6.1 Element Company Detail
11.6.2 Element Business Overview
11.6.3 Element Pharmaceutical lmpurity Testing Service Introduction
11.6.4 Element Revenue in Pharmaceutical lmpurity Testing Service Business (2018-2023)
11.6.5 Element Recent Development
11.7 Drug Development Solutions Limited
11.7.1 Drug Development Solutions Limited Company Detail
11.7.2 Drug Development Solutions Limited Business Overview
11.7.3 Drug Development Solutions Limited Pharmaceutical lmpurity Testing Service Introduction
11.7.4 Drug Development Solutions Limited Revenue in Pharmaceutical lmpurity Testing Service Business (2018-2023)
11.7.5 Drug Development Solutions Limited Recent Development
11.8 Leeder Analytical
11.8.1 Leeder Analytical Company Detail
11.8.2 Leeder Analytical Business Overview
11.8.3 Leeder Analytical Pharmaceutical lmpurity Testing Service Introduction
11.8.4 Leeder Analytical Revenue in Pharmaceutical lmpurity Testing Service Business (2018-2023)
11.8.5 Leeder Analytical Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Detail
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Pharmaceutical lmpurity Testing Service Introduction
11.9.4 Thermo Fisher Scientific Revenue in Pharmaceutical lmpurity Testing Service Business (2018-2023)
11.9.5 Thermo Fisher Scientific Recent Development
11.10 Selvita
11.10.1 Selvita Company Detail
11.10.2 Selvita Business Overview
11.10.3 Selvita Pharmaceutical lmpurity Testing Service Introduction
11.10.4 Selvita Revenue in Pharmaceutical lmpurity Testing Service Business (2018-2023)
11.10.5 Selvita Recent Development
11.11 Impact Analytical
11.11.1 Impact Analytical Company Detail
11.11.2 Impact Analytical Business Overview
11.11.3 Impact Analytical Pharmaceutical lmpurity Testing Service Introduction
11.11.4 Impact Analytical Revenue in Pharmaceutical lmpurity Testing Service Business (2018-2023)
11.11.5 Impact Analytical Recent Development
11.12 EKG Life Science Solutions, LLC (EKG Labs)
11.12.1 EKG Life Science Solutions, LLC (EKG Labs) Company Detail
11.12.2 EKG Life Science Solutions, LLC (EKG Labs) Business Overview
11.12.3 EKG Life Science Solutions, LLC (EKG Labs) Pharmaceutical lmpurity Testing Service Introduction
11.12.4 EKG Life Science Solutions, LLC (EKG Labs) Revenue in Pharmaceutical lmpurity Testing Service Business (2018-2023)
11.12.5 EKG Life Science Solutions, LLC (EKG Labs) Recent Development
11.13 Merck
11.13.1 Merck Company Detail
11.13.2 Merck Business Overview
11.13.3 Merck Pharmaceutical lmpurity Testing Service Introduction
11.13.4 Merck Revenue in Pharmaceutical lmpurity Testing Service Business (2018-2023)
11.13.5 Merck Recent Development
11.14 SwRI
11.14.1 SwRI Company Detail
11.14.2 SwRI Business Overview
11.14.3 SwRI Pharmaceutical lmpurity Testing Service Introduction
11.14.4 SwRI Revenue in Pharmaceutical lmpurity Testing Service Business (2018-2023)
11.14.5 SwRI Recent Development
11.15 Emery Pharma
11.15.1 Emery Pharma Company Detail
11.15.2 Emery Pharma Business Overview
11.15.3 Emery Pharma Pharmaceutical lmpurity Testing Service Introduction
11.15.4 Emery Pharma Revenue in Pharmaceutical lmpurity Testing Service Business (2018-2023)
11.15.5 Emery Pharma Recent Development
11.16 Cotecna
11.16.1 Cotecna Company Detail
11.16.2 Cotecna Business Overview
11.16.3 Cotecna Pharmaceutical lmpurity Testing Service Introduction
11.16.4 Cotecna Revenue in Pharmaceutical lmpurity Testing Service Business (2018-2023)
11.16.5 Cotecna Recent Development
11.17 Roche
11.17.1 Roche Company Detail
11.17.2 Roche Business Overview
11.17.3 Roche Pharmaceutical lmpurity Testing Service Introduction
11.17.4 Roche Revenue in Pharmaceutical lmpurity Testing Service Business (2018-2023)
11.17.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research